Orient Pharma (Taiwan) Insiders
4166 Stock | TWD 37.00 0.05 0.14% |
Recap of Orient Pharma's management performance can provide insight into the venture performance.
Orient |
Symbol | 4166 |
Name | Orient Pharma Co |
Type | Stock |
Country | Taiwan |
Exchange | TWO |
Information on Orient Pharma Co Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
Orient Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (8.89) % which means that it has lost $8.89 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (14.97) %, meaning that it generated substantial loss on money invested by shareholders. Orient Pharma's management efficiency ratios could be used to measure how well Orient Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Orient Pharma Workforce Comparison
Orient Pharma Co is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Major industry is presently estimated at about 348. Orient Pharma holds roughly 13.0 in number of employees claiming about 4% of equities under Drug Manufacturers - Major industry.
The company has Profit Margin (PM) of (61.79) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (79.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $79.63. Orient Pharma Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Orient Pharma Price Series Summation is a cross summation of Orient Pharma price series and its benchmark/peer.
About Orient Pharma Management Performance
The success or failure of an entity such as Orient Pharma often depends on how effective the management is. Orient Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orient management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orient management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. Orient Pharma Co., Ltd. is a subsidiary of Orient Europharma Co., Ltd. ORIENT PHARMA operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in Orient Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orient Pharma Co. Check Orient Pharma's Beneish M Score to see the likelihood of Orient Pharma's management manipulating its earnings.
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.